WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
Related articles：
Related suggestion：
Strengthening Building of Healthy FamiliesXi Meets with CPC National Congress DelegatesXi Meets Argentine President FernandezXi Meets French President MacronChina's used vehicle sales up in first 2 monthsOrganizations Continue Strengthening Cooperation on Protection of Women's Rights, InterestsWorld Insights: ChinaXi Arrives in Indonesia's Bali for G20 SummitXi Jinping: CPC Is a Party of the People and for the PeopleXi Focus: Xi Stresses Striving in Unity to Fulfill Goals Set by Party Congress
2.2628s , 5257.921875 kb
Copyright © 2024 Powered by 5 takeaways from the abortion pill case before the U.S. Supreme Court ,Culture Circle news portal